Katherine B. is a goal and people-oriented Clinical Research Scientist with over 10 years of experience in the clinical development of hematology-oncology therapies and T/B cell immunology discovery research. Currently serving as a Director at Eli Lilly and Company since 2024, Katherine has held various roles, including Postdoctoral Research Fellow at Genentech from 2017 to 2021, where they led pre-clinical studies and mentored interns. Katherine earned a Ph.D. in Immunology from Duke University and a BS in Biology from UC San Diego, and is also dedicated to community service and early education advocacy.
This person is not in any teams
This person is not in any offices